Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$71K Sell
4,132
-27,585
-87% -$634K ﹤0.01% 6405
2014
Q2
$945K Sell
31,717
-13,916
-30% -$334K ﹤0.01% 3603
2014
Q1
$1.14M Sell
45,633
-19,371
-30% -$567K ﹤0.01% 3357
2013
Q4
$1.87M Buy
65,004
+53,865
+484% +$1.58M ﹤0.01% 2864
2013
Q3
$367K Sell
11,139
-25,025
-69% -$778K ﹤0.01% 4499
2013
Q2
$1.12M Buy
+36,164
New +$970K ﹤0.01% 3201

Other funds holding INVA

UBS's INVA Position: Q3 2014 in Review

UBS reduced its Innoviva (INVA) stake by 87% in Q3 2014, selling an estimated $634K and leaving 4,132 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #6405.

UBS first reported a position in INVA in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.87M in Q4 2013. 120 funds tracked by Wall St. Rank hold INVA as of Q3 2014.

  • UBS held 4,132 shares of Innoviva worth $71K as of Q3 2014.
  • UBS sold 27,585 Innoviva shares in Q3 2014, an estimated $634K.
  • Innoviva made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6405 holding.
  • UBS first reported a position in Innoviva in Q2 2013 and has held it in 6 quarters since.
  • UBS's Innoviva position peaked at $1.87M in Q4 2013.
  • 120 funds tracked by Wall St. Rank held Innoviva as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.